We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Horseradish Complex Increases Sensitivity of Immunochemical Assays

By LabMedica International staff writers
Posted on 01 Aug 2017
Print article
Image: Microscopy images taken of Zika-infected primate placenta samples that were stained to detect Zika by immunohistochemistry. The left image shows a sample treated with the EASE protocol, with red/orange colored signals of Zika infection clearly visible (white arrows). The right image shows a sample treated with a standard protocol, and Zika virus - though present - was not detected (Photo courtesy of the University of Washington).
Image: Microscopy images taken of Zika-infected primate placenta samples that were stained to detect Zika by immunohistochemistry. The left image shows a sample treated with the EASE protocol, with red/orange colored signals of Zika infection clearly visible (white arrows). The right image shows a sample treated with a standard protocol, and Zika virus - though present - was not detected (Photo courtesy of the University of Washington).
A new technique boosts the sensitivity of immunochemical reactions that rely on the enzyme horseradish peroxidase from 100 to 1,000 times.

This enhanced sensitivity is achieved by combining horseradish peroxidase (HRP), one of the most popular reporter enzymes in biology, with polydopamine (PDA), arguably the most versatile coating material for surface treatment.

Previously, a simple dip-coating protocol had been demonstrated for spontaneous formation of a thin self-adherent PDA film onto a wide range of surfaces. Recently, however, investigators at the University of Washington (Seattle, USA) found that when dopamine was used in place of the typical HRP substrates, its polymerization rate increased over 300-fold. HRP aggregated dopamine molecules to form the polydopamine polymer chain. Polydopamine, in turn, accumulated on the surfaces of reaction vessels such as microtiter wells, small Petri dishes, or nanoparticles. Once the polydopamine was present, traditional protocols were followed with substantially increased test sensitivity.

PDA has been well known for its outstanding reactivity to the amine, sulfhydryl, and phenol groups in proteins, enabling site-specific deposition in the vicinity of HRP and subsequent sensitive detection based on absorption or fluorescence. Details of this approach, which the investigators called EASE (enzyme-accelerated signal enhancement), were published in the June 5, 2017, online edition of the journal Nature Biomedical Engineering.

"Common bioassays are the real workhorses of laboratory experiments and medical tests," said senior author Dr. Xiaohu Gao, professor of bioengineering at the University of Washington. "By boosting the sensitivity of these tests, we can enable more accurate medical diagnoses earlier in a disease or condition, and enable more certainty and less waste in the research process. EASE has potential to solve real, long-standing problems in research and medical tests."

"Scientists have been trying to improve the accuracy of these common tests for decades, but solutions often involve entirely new protocols or costly pieces of equipment," said Dr. Gao. "Understandably, researchers can be reluctant to invest in unfamiliar protocols or expensive new equipment -- but EASE is a simple addition to tried-and-true assays. It is like a software upgrade, instead of changing your operating system."

Related Links:
University of Washington

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Creatine Kinase-MB Assay
CK-MB Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more